# Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers

> **NCT02068313** · — · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 300 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **RADIATION:** Toxicity and outcome measures of IMRT

## Key facts

- **NCT ID:** NCT02068313
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2017-07
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2014-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068313, "Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02068313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*